Navigation Links
Next Inning Technology Research Identifies Winning Option Writing Strategies on Undervalued Stocks
Date:3/11/2009

PRINCETON, N.J., March 11 /PRNewswire/ -- Next Inning Technology Research (http://www.nextinning.com), a subscription service focused on semiconductor and technology stocks, announced it has published a series of reports updating outlooks for Analog Devices (NYSE: ADI), Maxim Integrated Products (Nasdaq: MXIM), Pfizer (NYSE: PFE), DNP Select Income Fund (NYSE: DNP), and more.

Throughout this challenging period in the market, Editor Paul McWilliams has helped his subscribers identify uniquely positioned tech sector opportunities. These include a specialty semiconductor stock that has returned 64% since McWilliams added it to the Next Inning model portfolio late last year.

By taking a free test drive of Next Inning, you'll receive real-time notification of Next Inning model portfolio buy and sell orders, the seven Next Inning Paradigm Papers covering key, long-term tech trends, and the exclusive "2009 Guide to Undervalued Tech Stocks." These reports cover nearly 100 technology companies and are chock full of charts and ratings that identify potential big winners for 2009 and which stocks investors should avoid. To accept this offer, visit the following link:

https://www.nextinning.com/subscribe/index.php?refer=prn790

The Black-Scholes model doesn't take into account intrinsic value when valuing options, only volatility and time. In a high volatility environment, there is often an opportunity to "harvest" a premium by writing options in high quality stable companies with limited downside risk to intrinsic value. Next Inning has applied this approach to the technology sector in the past with success, has recently identified several new ideas, and will publish a several more taking advantage of these anomalies.

McWilliams also looks at these topics:

-- Why does McWilliams think the price of DNP is artificially depressed? Does he think the 12%+ dividend is safe?

-- How can investors lock in returns greater than 20% with Pfizer and, at the same time, drop their risk exposure below what it would be if they just held the stock?

-- What strategy can investors use to lock in a 28% return with a very low risk exposure in the Tech sector?

-- Why does McWilliams think Analog Devices is destined to beat its guidance this quarter? How can investors lock in a 41% total return with Analog Devices, yet expose themselves to less risk than a typical Analog Devices shareholder?

Founded in September 2002, Next Inning's model portfolio has returned 118% since its inception versus 5% for the Nasdaq.

About Next Inning:

Next Inning is a subscription financial newsletter focused on technology stocks. Editor Paul McWilliams is a 20+-year semiconductor industry veteran.

NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit adviserinfo.sec.gov for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

CONTACT: Marcia Martin Next Inning Technology Research, +1-888-278-5515


'/>"/>
SOURCE Indie Research Advisors, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Olympic Gold Winning Supplement Lands in the US
2. Award Winning Photographer and Museum Founder to Donate Iconic Images In Support of the Innocence Project
3. Inspired Cancer Survivor Launches Customized Hair Replacement Techniques at Award-Winning Hair Salon
4. MidMichigan Health Cuts Out Trans Fats Beginning March 1
5. Disability Community Humble Beginnings Lead to Great Things at Disabled World
6. Governor Crist Proclaims Tobacco Free Florida Week Beginning February 27
7. Icagen Board Beginning to Follow Xmark Direction
8. A Newly Approved CMS Medicare Package Expands Reimbursement Coverage for Telehealth Originating Sites Beginning January 1, 2009
9. Pennsylvania to Offer Free Nicotine Replacement Therapy Kits Beginning Feb. 2
10. Author Shares Nine Resolutions for 2009 to Create a Winning Corporate Culture
11. Cadient Group Expands Award-Winning Capabilities with Key New Hires
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... WI (PRWEB) , ... October 13, 2017 , ... As ... in medicine known as “patient engagement.” The patient is doing more than filling out ... partners. , “There is an increasing emphasis in health care and research on ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its ... on Friday, November 3, 2017, beginning at 7:00 a.m. ... 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... and guidance for 2018, Hill-Rom executives will also highlight ... and long-range financial outlook through 2020. ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
Breaking Medicine Technology: